in

NATCO Pharma Q3 Results: Profit declines 37% to Rs 132 crore

NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports. The company had posted a consolidated net profit of Rs 212.7 crore in the third quarter of the previous fiscal year, NATCO…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Reserve Bank Of India To Issue Rs 50 Notes With Governor Sanjay Malhotra's Signature

MSCI rejig to lift India’s weight to 19% in EM index, unlocking inflows of up to $1 billion